ghk-cu injection clinical trial humans Copper Tripeptide-1 Peptide – Peptagon GHK-Cu Injection Redness & Welting

British Journal of Pharmacology

A higher level of oxidative stress was detected in patients with NASH compared to NAFLD and a reduction in the levels of 8-hydroxy-2-deoxyguanosine (8-OHdG) and GGT, as markers of oxidative stress, was highlighted in NASH patients treated with GSH, with a consequent reduction of alanine transaminase (ALT)

Always consult with a healthcare professional before starting any new supplement or research product.

Provides sustained release

Last reviewed: May 16, 2026 Last updated: May 16, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations